MT-8554

· Tanabe Pharma America, Inc.

Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for MT-8554, covering 2022-01-04 to 2025-12-22. Get the full timeline:

Most recent: Clinical Trial Update: Study to Assess the Efficacy, Safety and Tolerability of MT- 8554 in Subjects With Painful Diabetic Peripheral Neuropathy [Phase 2]

See pricing